Your browser doesn't support javascript.
loading
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocol.
Farmer, Andrew; Allen, Julie; Bartlett, Kiera; Bower, Peter; Chi, Yuan; French, David; Gudgin, Bernard; Holmes, Emily A; Horne, Robert; Hughes, Dyfrig A; Kenning, Cassandra; Locock, Louise; McSharry, Jenny; Miles, Lisa; Newhouse, Nikki; Rea, Rustam; Riga, Evgenia; Tarassenko, Lionel; Velardo, Carmelo; Williams, Nicola; Williams, Veronika; Yu, Ly-Mee.
Afiliação
  • Farmer A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK andrew.farmer@phc.ox.ac.uk.
  • Allen J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Bartlett K; The Division of Psychology and Mental Health, The University of Manchester, Manchester, UK.
  • Bower P; Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Manchester, UK.
  • Chi Y; The Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • French D; The Division of Psychology and Mental Health, The University of Manchester, Manchester, UK.
  • Gudgin B; Patient Representative, Oxford, UK.
  • Holmes EA; School of Health Sciences, Bangor University, Bangor, UK.
  • Horne R; UCL School of Pharmacy, University College London, London, UK.
  • Hughes DA; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.
  • Kenning C; Institute of Population Health, The University of Manchester, Manchester, UK.
  • Locock L; Health Service Research, University of Aberdeen, Aberdeen, UK.
  • McSharry J; Health Behaviour Change Research Group, School of Psychology, National University of Ireland Galway, Galway, Ireland.
  • Miles L; Division of Psychology and Mental Health, The University of Manchester, Manchester, UK.
  • Rea R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Riga E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Tarassenko L; The Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Velardo C; The Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Williams N; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Williams V; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
BMJ Open ; 9(12): e033504, 2019 12 29.
Article em En | MEDLINE | ID: mdl-31888938
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article